Parisi Gray Wealth Management Buys 10,561 Shares of iShares Biotechnology ETF $IBB

Parisi Gray Wealth Management purchased a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 10,561 shares of the financial services provider’s stock, valued at approximately $2,223,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of IBB. Bank of America Corp DE raised its holdings in shares of iShares Biotechnology ETF by 10.8% during the first quarter. Bank of America Corp DE now owns 7,259,501 shares of the financial services provider’s stock valued at $1,225,767,000 after purchasing an additional 707,343 shares during the period. Royal Bank of Canada boosted its position in shares of iShares Biotechnology ETF by 1.0% during the 1st quarter. Royal Bank of Canada now owns 737,128 shares of the financial services provider’s stock worth $124,464,000 after purchasing an additional 7,434 shares in the last quarter. Janney Montgomery Scott LLC grew its stake in shares of iShares Biotechnology ETF by 5.4% in the 1st quarter. Janney Montgomery Scott LLC now owns 652,818 shares of the financial services provider’s stock valued at $110,228,000 after buying an additional 33,268 shares during the period. Rockefeller Capital Management L.P. grew its stake in shares of iShares Biotechnology ETF by 16.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 147,707 shares of the financial services provider’s stock valued at $24,929,000 after buying an additional 21,052 shares during the period. Finally, Cetera Investment Advisers grew its stake in shares of iShares Biotechnology ETF by 9.4% in the 1st quarter. Cetera Investment Advisers now owns 128,530 shares of the financial services provider’s stock valued at $21,702,000 after buying an additional 10,994 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock traded down $5.42 during midday trading on Friday, reaching $201.99. The stock had a trading volume of 1,762,480 shares, compared to its average volume of 1,704,677. iShares Biotechnology ETF has a 12 month low of $152.17 and a 12 month high of $217.12. The company has a fifty day moving average price of $206.96 and a two-hundred day moving average price of $187.87.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 18th. Shareholders of record on Tuesday, September 15th were issued a $0.0112 dividend. The ex-dividend date was Tuesday, September 15th. This is a decrease from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. This represents a $0.04 annualized dividend and a yield of 0.0%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.